上海吉瑪制藥技術(shù)有限公司(Shanghai GenePharma Co.,Ltd) www.genepharma.com
上海吉瑪制藥技術(shù)有限公司(Shanghai GenePharma Co.,Ltd)是海外留學(xué)歸國人員在上海張江高科技園區(qū)創(chuàng)辦的高科技生物技術(shù)公司。
公司目標(biāo)：立足現(xiàn)有的技術(shù)優(yōu)勢、跨行業(yè)優(yōu)勢和成本優(yōu)勢，經(jīng)過公司全體員工的一致努力，成為RNA干擾產(chǎn)品在全球范圍內(nèi)的主要供應(yīng)、服務(wù)商。
技術(shù)平臺：目前公司擁有處于國際領(lǐng)先水平的siRNA化學(xué)合成的全部核心技術(shù)，包括RNA單體合成技術(shù)、普通和修飾的siRNA oligo合成技術(shù)、核酸熒光標(biāo)記技術(shù)、多種核苷酸化學(xué)修飾技術(shù)等。
員工隊伍: 上海吉瑪制藥擁有一支高素質(zhì)的員工隊伍，具備化學(xué)、生物學(xué)、醫(yī)學(xué)或相關(guān)專業(yè)背景，時刻將"敬業(yè)、熱情、團(tuán)結(jié)、創(chuàng)新"作為自己的行為準(zhǔn)則。公司研發(fā)團(tuán)隊以在國外留學(xué)和工作多年的資深學(xué)者領(lǐng)銜，由多位有多年工作經(jīng)驗的博士和碩士組成。
管理經(jīng)驗：公司主要創(chuàng)辦人之一，公司首席執(zhí)行官張佩琢博士有十幾年在英國的大學(xué)和公司里從事基因化學(xué)研究，產(chǎn)品開發(fā)和生產(chǎn)的經(jīng)驗，公司其它創(chuàng)辦人和高層管理人員也都擁有多年在國內(nèi)外同類公司從事公司全面管理, 研發(fā), 生產(chǎn)管理, 銷售管理, 質(zhì)量管理和后勤管理等多方面的經(jīng)驗。
產(chǎn)品種類：公司產(chǎn)品涵蓋化學(xué)合成的RNA單體，普通和修飾的siRNA oligo，生物大分子標(biāo)記用熒光染料；生物合成siRNA、shRNA；轉(zhuǎn)錄編碼shRNA的DNAs、轉(zhuǎn)錄編碼shRNA的質(zhì)粒載體；基于化學(xué)合成的RNAi的全程服務(wù)；基于載體調(diào)控的RNAi全程服務(wù)；siRNA相關(guān)試劑和RNA技術(shù)相關(guān)產(chǎn)品的銷售；常用的分子生物學(xué)試劑、實驗耗材銷售等。
市場份額：我們的RNAi相關(guān)產(chǎn)品不僅在國內(nèi)占據(jù)了很大的市場份額，而且正在源源不斷的銷往美國、日本、臺灣、新加坡、德國、瑞典、英國、法國、韓國等國家和地區(qū)， 公司目前銷售額超過一半來自海外市場。
公司環(huán)境：我們公司座落在上海張江高科技園區(qū)生物醫(yī)藥基地，近千平方米的現(xiàn)代化廠房，干凈、整潔的生產(chǎn)區(qū)，研發(fā)區(qū)和辦公區(qū)為公司的員工們提供了良好的工作環(huán)境，也為我們能在ISO9001標(biāo)準(zhǔn)下連續(xù)穩(wěn)定地生產(chǎn)出高質(zhì)量的產(chǎn)品提供了有力的保證。
質(zhì)量保證: 借助國外同類公司的經(jīng)驗, 公司按ISO9000的質(zhì)量管理標(biāo)準(zhǔn)在產(chǎn)品研發(fā)、生產(chǎn)、包裝、儲運(yùn)以及公司財務(wù)管理, 銷售管理和后勤管理等多方面采取標(biāo)準(zhǔn)化管理操作。并不懈地努力以期不斷完善各種操作流程, 以保證公司的產(chǎn)品和服務(wù)持續(xù)地得到客戶的滿意。
科研合作: 公司目前已經(jīng)與清華大學(xué)、北京大學(xué)等高等院校及數(shù)家著名生物醫(yī)藥公司建立了合作關(guān)系，公司誠摯地希望能在新藥研發(fā)以及診斷試劑的研發(fā)和生產(chǎn)等方向與國內(nèi)外的制藥公司、研究院所, 醫(yī)院等單位建立長期合作關(guān)系.
展望未來: RNAi技術(shù)在充滿挑戰(zhàn)的后基因組時代必將有廣闊的應(yīng)用前景,它將會在生物醫(yī)學(xué)研究中產(chǎn)生一種新的技術(shù)革命?；瘜W(xué)合成的siRNA 基因藥物的開發(fā)將成為極具發(fā)展前途的新興產(chǎn)業(yè)。

About US 

Company Introduction
Shanghai GenePharma is a biotech company founded in Shanghai Hi-Tech Park by a few scientists who have worked in various western countries.

Company Goal
GenePharma aims to become a global main supplier and service provider of RNAi products, utilizing our existing advantages of the technology, experience, low cost and the dedication of our staff.

Technical Platform
The company has all the internationally leading core technologies of siRNA chemical synthesis, which include the RNA monomer synthesis technology, the custom and chemically-modified siRNA oligo synthesis technology, the nucleic acid fluorescent labeling technology, and many nucleotide chemical modification technologies.

Staff
Shanghai GenePharma has a high-quality workforce, with chemical, biological, medical or related professional background, and it always treats "Dedication, Enthusiasm, Unity, and Innovation" as its code of conduct. The R&D team is led by senior scientists who have studied and worked aboard for many years and the experienced staff, many of whom have a masters or doctorate degree.

Management Experience 
The company CEO Dr. Pei-zuo Zhang, one of the founders, has more than ten years of experience in research, product development and production experience in gene chemistry in British universities and companies. The other founders and senior managers also have many years of experience of comprehensive management, R&D, production management, sales management, Q.C. management and logistics management in similar domestic or foreign companies.

Products
The companies products cover chemically-synthetic RNA monomer, custom siRNA oligo, chemically-modified RNA oligo, fluorescent dye for biological macromolecules marker; Biosynthesis siRNA, shRNA; DNAs encoding shRNA, plasmid vector encoding shRNA; RNAi service based on chemical synthesis, RNAi service based on vector regulation; siRNA related reagents and RNA-related product sales; common molecular biology reagent and laboratory supplies sales, etc.

Market Share
Our RNAi related products not only occupy a large domestic market share, but also are rising in the United States, Japan, Taiwan, Singapore, Germany, Sweden, the United Kingdom, France, South Korea and other countries and regions. The company currently sells more than half of its products to overseas markets.

Company Environment
Our company is located in the biomedical base, Shanghai Zhangjiang High-tech Park. It provides employees with a good working environment and approximately 1000 square meters of modern plant, clean and orderly production areas, R&D areas and office areas, which also guarantee us to produce high-quality products continuously and stably under ISO9001 standard.

Quality Assurance
With the experience of similar foreign companies, our company adopts standardized management practices in product development, production, packaging, storage, as well as its financial management, sales management and logistics management according to ISO9000 quality management standards. Furthermore, we put our tireless efforts on constantly improving various operational procedures to ensure that the company's products and services continue to satisfy our customers.

Scientific Research Cooperation
GenePharma has already established cooperative relations with Tsinghua University, Peking University and several famous biopharmaceutical companies; We sincerely hope that we could establish long-term co-operative relations with domestic and foreign pharmaceutical companies, research institutes, hospitals and other units in the development and production of new drugs and diagnostic reagents.

Forecast Future
RNAi technology has broad application prospects in a challenging post-genome era, and it will create a new technological revolution in biomedical research. The chemically-synthetic siRNA gene drug development will become a promising new industry.

GenePharma’s goal is 100% customer satisfaction.